申请人:Li Hui
公开号:US20090041786A1
公开(公告)日:2009-02-12
The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
这项发明涵盖了具有I-V公式的化合物以及使用这些化合物在治疗需要调节JAK通路或抑制JAK激酶,特别是JAK3的情况下可能具有治疗作用的组合物和方法。